NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.
CASRN: 608141-41-9
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the clinical use of apremilast during breastfeeding. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Apremilast
CAS Registry Number
608141-41-9
Drug Class
- Breastfeeding
- Analgesics
- Antirheumatic Agents
- Enzyme Inhibitors
- Phosphodiesterase Inhibitors
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Azilsartan[Drugs and Lactation Database (...]Review Azilsartan. Drugs and Lactation Database (LactMed). 2006
- Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitor.[J Med Chem. 2009]Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitor.Man HW, Schafer P, Wong LM, Patterson RT, Corral LG, Raymon H, Blease K, Leisten J, Shirley MA, Tang Y, et al. J Med Chem. 2009 Mar 26; 52(6):1522-4.
- Review Cilostazol[Drugs and Lactation Database (...]Review Cilostazol. Drugs and Lactation Database (LactMed). 2006
- Review Ropinirole[Drugs and Lactation Database (...]Review Ropinirole. Drugs and Lactation Database (LactMed). 2006
- Review Iloperidone[Drugs and Lactation Database (...]Review Iloperidone. Drugs and Lactation Database (LactMed). 2006
- Apremilast - Drugs and Lactation Database (LactMed)Apremilast - Drugs and Lactation Database (LactMed)
Your browsing activity is empty.
Activity recording is turned off.
See more...